TESARO is a biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. We see new possibilities to responsibly develop and commercialize innovative treatments where others may not. Relationships are vital to the success of our business, and we are committed to being a trusted partner to the cancer community.
Company Growth (employees)
Type
Public
HQ
Waltham, US
Founded
2010
Size (employees)
446 (est)
TESARO was founded in 2010 and is headquartered in Waltham, US

Key People at TESARO

Lonnie Moulde

Lonnie Moulde

Co-Founder, CEO
Rick Rodgers

Rick Rodgers

CFO
Mary Lynne Hedley

Mary Lynne Hedley

President, CSO and co-founder

TESARO Office Locations

TESARO has office in Waltham
Waltham, US

TESARO Metrics

TESARO Summary

Market capitalization

$8.2 b

Closing share price

$152.1
TESARO's current market capitalization is $8.2 b.

TESARO Financials

TESARO's revenue is $44.8 m in FY, 2016
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$44.8 m

Operating expense total

$92.4 m$167.3 m$236.4 m

EBIT

($92.4 m)($167.3 m)($236 m)

Net Income

($92.4 m)($171 m)($251.4 m)($387.5 m)

Operating cash flow

$4.9 m$126.6 m($26.7 m)

TESARO Market Value History

TESARO Online Presence

TESARO News

TESARO Company Life

You may also be interested in